Literature DB >> 15258708

MR spectroscopy of cervical spinal cord in patients with multiple sclerosis.

Ayşe Tuba Karagülle Kendi1, Funda Uysal Tan, Mustafa Kendi, Sevda Yilmaz, Sinef Huvaj, Serdar Tellioğlu.   

Abstract

MR spectroscopy (MRS) of the brain in patients with multiple sclerosis has been well studied. However, in vivo MRS of the spinal cord in patients with MR spectroscopy has not been reported to our knowledge. We performed MRS of normal-appearing cervical spinal cords in multiple sclerosis patients and in healthy controls. N-acetyl aspartate was shown to be reduced within the cervical spinal cord of multiple sclerosis patients when compared with healthy controls. This finding supports axonal loss and damage within even normal-appearing spinal cords of multiple sclerosis patients.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15258708     DOI: 10.1007/s00234-004-1231-1

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  13 in total

1.  Axonal injury or loss in the internal capsule and motor impairment in multiple sclerosis.

Authors:  M A Lee; A M Blamire; S Pendlebury; K H Ho; K R Mills; P Styles; J Palace; P M Matthews
Journal:  Arch Neurol       Date:  2000-01

2.  Cranial MR in spinal cord MS: diagnosing patients with isolated spinal cord symptoms.

Authors:  M K Edwards; M R Farlow; J C Stevens
Journal:  AJNR Am J Neuroradiol       Date:  1986 Nov-Dec       Impact factor: 3.825

3.  Metabolic changes in rabbit spinal cord after trauma: magnetic resonance spectroscopy studies.

Authors:  R Vink; L J Noble; S M Knoblach; M R Bendall; A I Faden
Journal:  Ann Neurol       Date:  1989-01       Impact factor: 10.422

4.  Axonal loss in normal-appearing white matter in a patient with acute MS.

Authors:  C Bjartmar; R P Kinkel; G Kidd; R A Rudick; B D Trapp
Journal:  Neurology       Date:  2001-10-09       Impact factor: 9.910

5.  Serial proton MR spectroscopy of contrast-enhancing multiple sclerosis plaques: absolute metabolic values over 2 years during a clinical pharmacological study.

Authors:  I Mader; W Roser; L Kappos; G Hagberg; J Seelig; E W Radue; W Steinbrich
Journal:  AJNR Am J Neuroradiol       Date:  2000-08       Impact factor: 3.825

6.  Neurological disability correlates with spinal cord axonal loss and reduced N-acetyl aspartate in chronic multiple sclerosis patients.

Authors:  C Bjartmar; G Kidd; S Mörk; R Rudick; B D Trapp
Journal:  Ann Neurol       Date:  2000-12       Impact factor: 10.422

7.  Differentiation of multiple sclerosis from other inflammatory disorders and cerebrovascular disease: value of spinal MR imaging.

Authors:  Joost C J Bot; Frederik Barkhof; Geert Lycklama à Nijeholt; Dirkjan van Schaardenburg; Alexandre E Voskuyl; Herman J Ader; Jolanda A L Pijnenburg; Chris H Polman; Bernard M J Uitdehaag; Erik G J Vermeulen; Jonas A Castelijns
Journal:  Radiology       Date:  2002-04       Impact factor: 11.105

8.  Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis. Results of a longitudinal magnetic resonance spectroscopy study.

Authors:  N De Stefano; P M Matthews; L Fu; S Narayanan; J Stanley; G S Francis; J P Antel; D L Arnold
Journal:  Brain       Date:  1998-08       Impact factor: 13.501

9.  Multiple sclerosis in the spinal cord: MR appearance and correlation with clinical parameters.

Authors:  L M Tartaglino; D P Friedman; A E Flanders; F D Lublin; R L Knobler; M Liem
Journal:  Radiology       Date:  1995-06       Impact factor: 11.105

10.  Use of proton magnetic resonance spectroscopy for monitoring disease progression in multiple sclerosis.

Authors:  D L Arnold; G T Riess; P M Matthews; G S Francis; D L Collins; C Wolfson; J P Antel
Journal:  Ann Neurol       Date:  1994-07       Impact factor: 10.422

View more
  24 in total

Review 1.  Magnetic resonance spectroscopy in the monitoring of multiple sclerosis.

Authors:  Ponnada A Narayana
Journal:  J Neuroimaging       Date:  2005       Impact factor: 2.486

Review 2.  Magnetic resonance imaging of myelin.

Authors:  Cornelia Laule; Irene M Vavasour; Shannon H Kolind; David K B Li; Tony L Traboulsee; G R Wayne Moore; Alex L MacKay
Journal:  Neurotherapeutics       Date:  2007-07       Impact factor: 7.620

Review 3.  MRI in multiple sclerosis: what's inside the toolbox?

Authors:  Mohit Neema; James Stankiewicz; Ashish Arora; Zachary D Guss; Rohit Bakshi
Journal:  Neurotherapeutics       Date:  2007-10       Impact factor: 7.620

Review 4.  Spinal cord MRI in multiple sclerosis--diagnostic, prognostic and clinical value.

Authors:  Hugh Kearney; David H Miller; Olga Ciccarelli
Journal:  Nat Rev Neurol       Date:  2015-05-26       Impact factor: 42.937

Review 5.  (1)H-MR spectroscopy in the human spinal cord.

Authors:  A Hock; A Henning; P Boesiger; S S Kollias
Journal:  AJNR Am J Neuroradiol       Date:  2012-12-13       Impact factor: 3.825

Review 6.  Advanced MRI strategies for assessing spinal cord injury.

Authors:  Seth A Smith; James J Pekar; Peter C M van Zijl
Journal:  Handb Clin Neurol       Date:  2012

7.  In vivo intermolecular zero-quantum coherence MR spectroscopy in the rat spinal cord at 17.6 T: a feasibility study.

Authors:  David Z Balla; Cornelius Faber
Journal:  MAGMA       Date:  2007-09-18       Impact factor: 2.310

8.  2D phase-sensitive inversion recovery imaging to measure in vivo spinal cord gray and white matter areas in clinically feasible acquisition times.

Authors:  Nico Papinutto; Regina Schlaeger; Valentina Panara; Eduardo Caverzasi; Sinyeob Ahn; Kevin J Johnson; Alyssa H Zhu; William A Stern; Gerhard Laub; Stephen L Hauser; Roland G Henry
Journal:  J Magn Reson Imaging       Date:  2014-12-08       Impact factor: 4.813

9.  Neuronal and axonal degeneration in experimental spinal cord injury: in vivo proton magnetic resonance spectroscopy and histology.

Authors:  Junchao Qian; Juan J Herrera; Ponnada A Narayana
Journal:  J Neurotrauma       Date:  2010-03       Impact factor: 5.269

Review 10.  MRI in multiple sclerosis: current status and future prospects.

Authors:  Rohit Bakshi; Alan J Thompson; Maria A Rocca; Daniel Pelletier; Vincent Dousset; Frederik Barkhof; Matilde Inglese; Charles R G Guttmann; Mark A Horsfield; Massimo Filippi
Journal:  Lancet Neurol       Date:  2008-07       Impact factor: 44.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.